An Analysis of Proteochemometric and Conformal Prediction Machine Learning Protein-Ligand Binding Affinity Models
Authors:
Open Access
- 24 June 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 7, 93
Abstract
Protein-ligand binding affinity is a key pharmacodynamic endpoint in drug discovery. Sole reliance on experimental design, make, and test cycles is costly and time consuming, providing an opportunity for computational methods to assist. Herein, we present results comparing random forest and feed-forward neural network proteochemometric models for their ability to predict pIC50 measurements for held out generic Bemis-Murcko scaffolds. In addition, we assess the ability of conformal prediction to provide calibrated prediction intervals in both a retrospective and semi-prospective test using the recently released Grand Challenge 4 data set as an external test set. In total, random forest and deep neural network proteochemometric models show quality retrospective performance but suffer in the semi-prospective setting. However, the conformal predictor prediction intervals prove to be well-calibrated both retrospectively and semi-prospectively showing that they can be used to guide hit discovery and lead optimization campaigns.Keywords
All Related Versions
This publication has 38 references indexed in Scilit:
- Introducing Conformal Prediction in Predictive Modeling. A Transparent and Flexible Alternative to Applicability Domain DeterminationJournal of Chemical Information and Modeling, 2014
- QSAR Modeling: Where Have You Been? Where Are You Going To?Journal of Medicinal Chemistry, 2013
- Accuracy Assessment and Automation of Free Energy Calculations for Drug DesignJournal of Chemical Information and Modeling, 2013
- Visually Interpretable Models of Kinase Selectivity Related Features Derived from Field-Based ProteochemometricsJournal of Chemical Information and Modeling, 2013
- Comparability of Mixed IC50 Data – A Statistical AnalysisPLOS ONE, 2013
- Study on human GPCR–inhibitor interactions by proteochemometric modelingGene, 2013
- Perspective: Alchemical free energy calculations for drug discoveryThe Journal of Chemical Physics, 2012
- Alchemical free energy methods for drug discovery: progress and challengesCurrent Opinion in Structural Biology, 2011
- Perspective on Free-Energy Perturbation Calculations for Chemical EquilibriaJournal of Chemical Theory and Computation, 2008
- Proteochemometric modeling of HIV protease susceptibilityBMC Bioinformatics, 2008